Sanofi Aktie
91,72EUR | 0,38EUR | 0,42% |
WKN: 920657 / ISIN: FR0000120578
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 89,40 |
L'Oréal SA | 9,32 |
Government Pension Fund - Global (The) | 2,26 |
Dodge & Cox | 1,77 |
Sanofi | 1,28 |
Vanguard Total International Stock Index Fund | 1,21 |
Dodge & Cox International Stock Fund | 1,17 |
Vanguard Developed Markets Index Fund | 0,75 |
Capital Income Builder | 0,64 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 100 409 | 99 412 | 95 442 | 91 573 | 87 994 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,36 | 0,36 | 0,40 | 0,47 | 0,49 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 28 611 | 33 703 | 30 564 | 34 026 | 30 655 |
Summe Anlagevermögen | 84 125 | 80 826 | 89 678 | 92 696 | 95 809 |
Summe Aktiva | 112 736 | 114 529 | 120 242 | 126 722 | 126 464 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 53 628 | 51 382 | 51 211 | 51 570 | 52 111 |
Summe Eigenkapital | 59 108 | 63 147 | 69 031 | 75 152 | 74 353 |
Summe Passiva | 112 736 | 114 529 | 120 242 | 126 722 | 126 464 |
Adresse
46, avenue de la Grande Armée, 75017 Paris | |
Telefon | +33 (1) 53-77-40-00 |
Fax | +33 (1) 53-77-44-03 |
Internet | http://www.sanofi.com |
Management
Alexandra Roger
Head-Legal Corporate & Finance |
Anne-Francoise Nesmes
Independent Non-Executive Director |
Antoine Yver
Independent Director |
Arnaud Delépine
Investor Relations Contact |
Audrey Duval Derveloy
Executive Vice President & Head-Corporate Affairs |
Barbara Lavernos
Independent Director |
Brendan OCallaghan
exec Vice President-Global Manufacturing & Supply |
Carole Gabriella Ferrand
Independent Director |
Christophe Babule
Non-Independent Director |
Clotilde Delbos
Independent Director |
Dietmar P. Berger
Chief Medical Officer & Global Head-Development |
Emile Voest
Independent Director |
Emmanuel Frenehard
Chief Digital Officer & Executive Vice President |
Fabienne Lecorvaisier
Independent Director |
François-Xavier Michel Marie Roger
Chief Financial Officer |
Frédéric Oudéa
Independent Chairman |
Gilles Schnepp
Independent Director |
Houman Ashrafian
Executive VP, Head-Research & Development |
John Sundy
Independent Director |
Julie van Ongevalle
Executive Vice President-Consumer Healthcare |
Lise Kingo
Independent Director |
Madeleine Roach
Executive Vice President-Business Operations |
Natalie Bickford
Chief People Officer & Executive Vice President |
Nestle Frank
Chief Scientific Officer & Global Head-Research |
Olivier Antoine M. Charmeil
Executive Vice President-General Medicines |
Patrick Kron
Independent Director |
Paul Hudson
Chief Executive Officer & Director |
Preethi Sundaram
Director-Global Clinical Research |
Rachel Duan
Independent Director |
Raj Verma
Chief Diversity, Culture & Experience Officer |
Roy Papatheodorou
Executive Vice President & General Counsel |
Thomas Kudsk Larsen
Head-Investor Relations |
Wolfgang Laux
Non-Independent Director |
Yann Tran
Non-Independent Director |